Η Κλινική Έρευνα στις Φαρμακευτικές Εταιρείες - Το παράδειγμα της Bayer

1. ///////////
Η Κλινική Έρευνα
στις Φαρμακευτικές
Εταιρείες – Το
παράδειγμα της
Bayer
Κώτσανης Θανάσης, Καρδιολόγος
Medical Director Greece & Cyprus
Southern Mediterranean & Black Sea (SMBS) Cluster
Medical Director
11th Clinical Research Conference
‘’Το μέλλον δεν μπορεί να περιμένει την Ελλάδα’’
Τρίτη 13 Δεκεμβρίου 2022
Divani Caravel

2. World and science is changing fast. VUCA is the new norm.
Patient access to breakthrough therapies is full of challenges
2
Leaps in life sciences
Genome editing
Aging population
Breakthrough innovation
Personalized medicine
Bioprinting of organs
Artificial intelligence
Digitalization
Translation of academia research
New pathways for
treatments needed
Additional approaches
to be tested
Changes in policies &
regulatory environment
Reimbursement
Time
Risk
Investment

3. Innovation for diseases with a high
unmet medical need
3
Innovation is a cornerstone of our mission
“Science for a better life”
We strongly focus on disease mechanisms
and further deepening our disease
understanding
We complement our comprehensive in-house
expertise with the know-how of excellent
partners from academia and industry to speed
up innovation.
Digital transformation is another key driver
and strategic component of our new R&D Innovation
Strategy.

4. Leaps has invested in potential breakthrough technologies.
Dare to Leap!!! Partnering for a better life

5. Global drug discovery network is complemented by Innovation Centers facilitating external collaborations
It takes more than two to Tango:
Bayer Pharma’s R&D Powerhouse: Collaboration in Drug Discovery
5
// East Coast
Innovation
Center
Boston
// R&D of
Biologics
// West Coast
Innovation
Center
// CoLaborator
// R&D
Whippany
// Oncology
// Gynecology
// Cross-
Indication
Platform
// CoLaborator
// R&D
Wuppertal
Cologne
// Cardiovascular
Diseases
// R&D of
Biologics
// Cross-
Indication
Platform
// R&D
Turku
// Polymer-based
Drug Delivery
Systems
Beijing
// R&D
// Innovation
Center China
// Innovation
Center
Singapore
Singapore
Tokyo
// R&D
// R&D
// Innovation Center
Japan
// Oncology
Thorium Platform
Oslo
Drug Discovery Innovation Center
Osaka
San Francisco
Berkeley
Berlin

6. Roughly 60 percent of our current clinical
programs are being advanced through
external collaborations
And we don’t stop collaborating: Bayer Pharma Partnering
6
Collaboration in Research

7. Collaboration platforms
From the traditional model to co creation: Partnering for better life
7

8. Pharmaceuticals Division: Overview Development Portfolio (August 2022)
8
Diverse Portfolio in therapeutic areas of high unmet need

9. Create an ecosystem for the transformation of healthcare in the future
through enabling research & innovation and empowering HCPs, patients
and researchers for better health.
Bayer Scholarships
foundation
CTA in Uni of
Athens
HCPs career
days
Level-up
program
Digital Health
thinktank
Telehealth pilots
Patient Safety
campaign
Clinical Trials
Academy
Clinical research
network
Patient
workshops in
RCTs
Advancing Medical Education Leveling up Clinical Practice Empowering clinical research
Advancing Medical Education
Familiarizing with clinical research & innovation
through the early steps of medical education:
• Raise awareness around the value of clinical
research & innovation
• Provide the “tools and ammunitions” to excel
• Share diverse perspectives on career
opportunities
Leveling up Clinical Practice
Creating awareness, framework and opportunities
for adopting innovation
• Fast adoption of innovative healthcare services
• Build up health literacy on patient safety and
raise awareness on healthcare transformation
• Enhance HCPs/patients engagement for
improved disease management
Empowering clinical research
Build framework for continuous improvement and
research optimization
• Empowering clinical researchers
• Adopting digital innovation in clinical research
• Raise awareness among patients on benefits of
clinical research
• Optimizing clinical trials approval framework
Our vision: Laying the foundations for the future of healthcare in Greece

10. Educating and engaging various stakeholders in Clinical Research
Empowering Clinical research
Clinical Trials
Academy
Clinical research
network
Patient
workshops in
RCTs
Empowering clinical research
Educate selected physicians, nurses and other
stakeholders on the principles of GPP & RCTs to up-
skill themselves as investigators, coordinators and
enablers in clinical trials.
One-day events & fora for sharing the megatrends
and best practices in clinical research
Develop series of webinars/workshops with PAG
representatives to improve awareness on clinical
research and HCP-patient relationship

11. Extroversion and Collaboration are the keys to unlock patients’
access to innovative therapies that answer medical unmet needs.
“In a VUCA environment, you need
to go fast and far. So, go together.”

12. ///////////
Thank you!